These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 6174401)
1. The binding affinity of polyoma-tumor specific antigen (TSTA) to receptors of lymphocyte populations. Ochałek T; Porwit-Bóbr Z; Radzioch D Folia Histochem Cytochem (Krakow); 1981; 19(4):189-96. PubMed ID: 6174401 [TBL] [Abstract][Full Text] [Related]
2. Quantitative assay of binding affinity of tumor associated antigen (TAA) to receptors in monitoring of lymphocyte populations generated in culture. Ochałek T; Porwit-Bóbr Z; Radzioch D Folia Histochem Cytochem (Krakow); 1982; 20(3-4):103-8. PubMed ID: 7160780 [TBL] [Abstract][Full Text] [Related]
3. [Heterogeneity of T-cell populations. Proof of the non-identity of killer T-cells and helper T-cells]. Khaitov RM; Gambarov SS; Norimov ASh Tsitologiia; 1976 Dec; 18(12):1498-1501. PubMed ID: 1088322 [No Abstract] [Full Text] [Related]
4. Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. Allison JP; McIntyre BW; Bloch D J Immunol; 1982 Nov; 129(5):2293-300. PubMed ID: 6181166 [TBL] [Abstract][Full Text] [Related]
5. Antigen receptors on murine T lymphocytes in contact sensitivity. II. Presentation and characterization of syngeneic anti-idiotype serum against DNFB-sensitized T cells. Moorhead JW; Sy MS J Immunol; 1982 Jun; 128(6):2533-8. PubMed ID: 6176644 [TBL] [Abstract][Full Text] [Related]
6. The acquisition of receptors for peanut agglutinin by peanut agglutinin-negative thymocytes and peripheral T cells. Schrader JW; Chen WF; Scollay R J Immunol; 1982 Aug; 129(2):545-9. PubMed ID: 6979577 [TBL] [Abstract][Full Text] [Related]
7. Polyoma antigen driven T lymphocytes with antitumor and DTH activity in CBA mice. Ochałek T; Cadel Z Neoplasma; 1988; 35(3):271-8. PubMed ID: 3261395 [TBL] [Abstract][Full Text] [Related]
8. Characterization of antigen-binding receptors in vitro. II. Antigen-binding capacity and affinity of lymphoid receptors after immunization. Benfari MJ; Cooperband SR; Moolten FL J Immunol; 1977 Oct; 119(4):1432-8. PubMed ID: 302283 [TBL] [Abstract][Full Text] [Related]
9. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor. Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614 [TBL] [Abstract][Full Text] [Related]
10. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. LaTemple DC; Abrams JT; Zhang SY; Galili U Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604 [TBL] [Abstract][Full Text] [Related]
11. The effect of soluble antigens from polyoma tumor and liver cells on stimulation of lymph nodes measured by incorporation of 14C-leucine. Porwit-Bóbr Z; Radziejowska A; Slowik M; Stanisz A?WW Arch Immunol Ther Exp (Warsz); 1975; 23(2):257-61. PubMed ID: 167672 [TBL] [Abstract][Full Text] [Related]
12. Dominant V beta 8 gene usage in response to TNP: failure to use other V beta chains following removal of V beta 8+ T cells by monoclonal antibody in vivo. Dieli F; Asherson GL; Sireci G; Tantillo G; del Carpio C; Salerno A Immunology; 1994 May; 82(1):99-105. PubMed ID: 8045598 [TBL] [Abstract][Full Text] [Related]
13. Heterologous antisera to Lyt-1+, 2- -derived antigen-binding factor detect a subfactor of an antigen-specific suppressor factor and cell surface proteins on Lyt-1+, 2- and Lyt-1-, 2+ T cells. Cone RE; Rosenstein RW; Tite J; Ptak W; Gershon RK J Immunol; 1983 May; 130(5):2083-7. PubMed ID: 6187836 [TBL] [Abstract][Full Text] [Related]
14. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Hultkrantz S; Ostman S; Telemo E Immunology; 2005 Nov; 116(3):362-72. PubMed ID: 16236126 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a loss of recirculating capacity of T-cells after antigenic stimulation. Jacobsson H; Blomgren H Clin Exp Immunol; 1973 Mar; 13(3):439-53. PubMed ID: 4540783 [TBL] [Abstract][Full Text] [Related]
16. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells. Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679 [TBL] [Abstract][Full Text] [Related]
17. [Increase of the concentration of effector T-lymphocytes specific to antigens H2. 1. Elution of T-lymphocytes from the allogeneic target cells]. Brondz BD; Egorova CG Tsitologiia; 1976 Nov; 18(11):1387-92. PubMed ID: 70094 [TBL] [Abstract][Full Text] [Related]
18. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. Wang J; Saffold S; Cao X; Krauss J; Chen W J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528 [TBL] [Abstract][Full Text] [Related]
19. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells. Inoue M; Plautz GE; Shu S Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987 [TBL] [Abstract][Full Text] [Related]
20. The T lymphocyte surface in development. A study of the electrokinetic, antigenic and ultrastructural properties of T lymphocytes in mouse thymus and lymph nodes. Zeiller K; Schindler RK; Liebich HG Isr J Med Sci; 1975 Dec; 11(12):1242-66. PubMed ID: 56320 [No Abstract] [Full Text] [Related] [Next] [New Search]